Acute myeloid leukemia in the elderly: what constitutes treatment value?-Reference-Cited by-同舟云学术

Acute myeloid leukemia in the elderly: what constitutes treatment value?

Published:2018-11-08 Issue:5 Volume:60 Page:1164-1170
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Nabhan Chadi¹,Kamat Siddhesh²,Karl Kish Jonathan¹

Affiliation:

1. Cardinal Health Specialty Solutions, Cardinal Health, Dublin, OH, USA;

2. Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1520992

Reference19 articles.

1. Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review. Bethesda, MD: National Cancer Institute; 1975–2015. https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website, April 2018.

2. Initial therapy for acute myeloid leukemia in older patients: principles of care

3. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome:

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-intensive acute myeloid leukemia therapies for older patients;Expert Review of Hematology;2023-03-02

2. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia;Frontiers in Immunology;2023-01-20

3. Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy?;Leukemia & Lymphoma;2020-01-13

4. New perspectives on treatment strategies for patient with acute myeloid leukemia and complex karyotype abnormalities after percutaneous coronary intervention;Medicine;2019-07